This study used genome-wide association and molecular quantitative trait loci (QTL) data to map shared and distinct genetic signals linking amyotrophic lateral sclerosis (ALS), sporadic frontotemporal dementia (sFTD) and a range of cognitive traits. The authors applied pleiotropy mapping, colocalisation and multiple gene prioritisation approaches to identify loci and genes that contribute to overlap between motor and cognitive phenotypes.
Summary statistics for ALS, sFTD and several cognitive traits were obtained from public resources. The authors referenced GWAS Catalog accessions and other public repositories for traits including general intelligence, cognitive performance, educational attainment and cognitive subdomains. Molecular QTL data used for colocalisation analyses included MetaBrain and single-cell RNA-seq eQTLs from the ROSMAP cohort. The manuscript states that MTAG summary statistics resulting from this study will be deposited in the GWAS Catalog on publication.
Using pleiotropy mapping and colocalisation, the study identified discrete counts of shared loci across trait pairs: 26 loci shared between ALS and cognitive traits (denoted ALS-COG), 5 loci shared between ALS and sFTD (ALS-sFTD), and 7 loci shared between sFTD and cognitive traits (sFTD-COG). These locus-level results frame subsequent gene prioritisation and pathway analyses reported by the authors.
On the ALS-COG axis, the authors prioritised multiple candidate genes at colocalised loci. Highlighted genes include MEF2C, AXIN1, CLCN3, EFL1, SLC9A8, TSNARE1, EXOC4 and CLN3. Among these, MEF2C showed the strongest convergent evidence: it was supported by several gene-prioritisation methods (PoPs, nearest gene, SMR) and exhibited a three-way colocalised signal involving ALS, cognitive traits and an MEF2C eQTL in cerebellum. The combination of colocalisation and multiple prioritisation lines of evidence places MEF2C as a top pleiotropic candidate linking ALS and cognition in these analyses.
Genes mapped to ALS-COG loci were enriched for functions related to synapse organisation, vesicle trafficking and ion homeostasis. These pathway-level enrichments suggest biological mechanisms through which genetic variation may contribute to cognitive impairment observed in a subset of individuals with ALS, implicating neuronal connectivity, synaptic function and ion regulation as relevant processes.
On the ALS–sFTD axis, the strongest-supported locus implicated UNC13A. The authors report colocalisation between ALS and sFTD at this locus and SMR (summary-based Mendelian randomisation) evidence consistent with a splicing-mediated effect. UNC13A therefore emerges in these results as a prioritized pleiotropic gene with a plausible molecular mechanism linking motor neuron disease and frontotemporal degeneration.
For the sFTD–cognition axis, the analyses identified the MAPT/17q21.31 locus and APOE as joint drivers of shared association signals. These loci are reported by the authors as principal contributors to genetic overlap between sporadic FTD and cognitive trait GWAS in the datasets analysed.
The authors interpret their results to mean that the cognitive dimension of ALS has a locus-resolved genetic architecture that is partially distinct from the genetic relationship between ALS and sFTD. They nominate MEF2C for ALS–cognition, UNC13A for ALS–sFTD, and MAPT/17q21.31 (with APOE) for sFTD–cognition as top pleiotropic candidates to prioritise for further functional follow-up.
The preprint reports that summary statistics for all analysed GWAS traits are publicly available from the GWAS Catalog, SSGAC Data Portal, UCL Research Data Repository and other listed sources. Molecular QTL resources used include MetaBrain and ROSMAP single-cell eQTLs. The authors state that MTAG summary statistics resulting from this study will be deposited in the GWAS Catalog upon publication. Ethical approval statements, participant consent confirmation and competing interest declarations are provided in the manuscript. Declared funders include the Motor Neurone Disease Association and Science Foundation Ireland among others.